Consolidated statement of changes in equity
January 1 – December 31
Attributable to shareholders of medmix Ltd | ||||||||||||||||||
millions of CHF | Share capital | Retained earnings | Treasury shares | Cash flow hedge reserve | Currency translation adjustment | Total | Non-controlling interests | Total equity | ||||||||||
Equity as of January 1, 2024 | 0.4 | 529.8 | –15.2 | –0.9 | –48.7 | 465.4 | 9.0 | 474.3 | ||||||||||
Comprehensive income for the period: | ||||||||||||||||||
Net income | –7.4 | –7.4 | 1.0 | –6.4 | ||||||||||||||
– Cash flow hedges, net of tax | – | – | – | –5.0 | – | –5.0 | – | –5.0 | ||||||||||
– Remeasurements of defined benefit plans, net of tax | – | –1.3 | – | – | – | –1.3 | – | –1.3 | ||||||||||
– Currency translation differences | – | – | – | – | – | 6.3 | 6.3 | 0.4 | 6.7 | |||||||||
Other comprehensive income | – | –1.3 | – | –5.0 | 6.3 | –0.0 | 0.4 | 0.3 | ||||||||||
Total comprehensive income for the period | – | –8.7 | – | –5.0 | 6.3 | –7.4 | 1.4 | –6.0 | ||||||||||
Subsequent measurement of put option liabilities | – | –5.0 | – | – | – | –5.0 | – | –5.0 | ||||||||||
Contribution to the Sulzer group | – | –0.1 | – | – | – | –0.1 | – | –0.1 | ||||||||||
Transactions with owners of the company: | ||||||||||||||||||
Allocation of treasury shares to share plan participants | – | –1.1 | 1.1 | – | – | – | – | – | ||||||||||
Purchase of treasury shares | – | – | –0.5 | – | – | –0.5 | – | –0.5 | ||||||||||
Share-based payments | – | 4.4 | – | – | – | 4.4 | – | 4.4 | ||||||||||
Dividends to shareholders of medmix Ltd | – | –20.4 | – | – | – | –20.4 | – | –20.4 | ||||||||||
Equity as of December 31, 2024 | 0.4 | 498.9 | –14.5 | –6.0 | –42.4 | 436.4 | 10.3 | 446.7 | ||||||||||
Equity as of January 1, 2025 | 0.4 | 498.9 | –14.5 | –6.0 | –42.4 | 436.4 | 10.3 | 446.7 | ||||||||||
Comprehensive income for the period: | ||||||||||||||||||
Net income | 6.4 | 6.4 | 0.6 | 7.0 | ||||||||||||||
– Cash flow hedges, net of tax | – | – | – | 2.6 | – | 2.6 | – | 2.6 | ||||||||||
– Remeasurements of defined benefit plans, net of tax | – | 12.6 | – | – | – | 12.6 | – | 12.6 | ||||||||||
– Currency translation differences | – | – | – | – | –11.2 | –11.2 | –0.9 | –12.2 | ||||||||||
Other comprehensive income | – | 12.6 | – | 2.6 | –11.2 | 3.9 | –0.9 | 3.0 | ||||||||||
Total comprehensive income for the period | – | 19.0 | – | 2.6 | –11.2 | 10.3 | –0.3 | 10.0 | ||||||||||
Subsequent measurement of put option liabilities | – | 0.9 | – | – | – | 0.9 | – | 0.9 | ||||||||||
Transactions with owners of the company: | ||||||||||||||||||
Allocation of treasury shares to share plan participants | – | –3.7 | 3.7 | – | – | – | – | – | ||||||||||
Purchase of treasury shares | – | – | –2.6 | – | – | –2.6 | – | –2.6 | ||||||||||
Share-based payments | – | 3.1 | – | – | – | 3.1 | – | 3.1 | ||||||||||
Dividends to shareholders of medmix Ltd | – | –20.4 | – | – | – | –20.4 | – | –20.4 | ||||||||||
Dividends to non-controlling interests in subsidiaries | – | –2.0 | – | – | – | –2.0 | –3.0 | –5.0 | ||||||||||
Equity as of December 31, 2025 | 0.4 | 495.8 | –13.4 | –3.4 | –53.6 | 425.7 | 7.1 | 432.8 | ||||||||||